Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
2 papers
This review explains how ketamine, a drug that blocks NMDA receptors, might work for people with treatment‑resistant depression. It says one injection of ketamine can rapidly reduce depressive symptoms, including acute suicidal behavior. The paper describes steps that could explain this: ketamine may raise glutamate, trigger growth of neuron branches,…
This article describes one patient who developed increased sexual urges after bupropion was added to his ongoing fluoxetine treatment. The urges dropped after bupropion was stopped and replaced with mirtazapine. The authors review other studies showing bupropion usually causes fewer sexual problems than SSRIs but can sometimes raise libido, and…
